Aisher (Shenzhen) Drug Research and Development Co., Ltd., established on 2016-07-26, Business scope includes general business items:Technical process development services for pharmaceutical products;chemical compound(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)research and development,detection,Sales;Domestic Trade;technical consulting(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).,The licensing program is:R&D of pharmaceutical intermediates,production and sales;Synthesis of drug-related compounds.

Shenzhen Xianggen Biotechnology Co., Ltd., established on 2008-12-22, Business scope includes general business items:new drug,R&D of pharmaceutical intermediates,Sales;Fine Chemicals(Free of Hazardous Chemicals)research and development,Sales;Research and development of biomedicine and medical devices,detection,technology transfer,technical consulting;Domestic Trade;Import and export,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated);Research and development of chemical compounds,technology transfer,technical consulting(No restricted items);Information Technology Services;Provide investment consulting and management services for enterprises;Consulting management services permitted by law in other countries.,The licensing program is:Research and development, purchase and sale of biomedicine and medical device technology(no law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).

Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China.

Henan Gaiya Biotechnology Co., Ltd., established on 2018-03-27, Business scope includes biotechnology development,technical consulting,technology transfer,Technical Services;Intellectual Property Consulting Services;Sales:laboratory equipment,Chemical Products(flammable,Explosive,Precursor,Excluding hazardous chemicals),Class I medical device,rubber products,plastic products,Glass product,metal products,Instrumentation,Office Supplies,handcrafted gift,Daily necessities,Wujinjiaodian,electronic product,Communication equipment.

Beijing Xinlingxian Medical Technology Development Co., Ltd., part of Henan Taloph Pharmaceutical Stock Co., Ltd., is a Chinese company involved in commercial physical and biological research. Henan Taloph Pharmaceutical Stock Co., Ltd. acquired Beijing Xinlingxian Medical Technology Development Co., Ltd. on February 15, 2015 for $57.73 million.

Nanjing Hairun Pharmaceutical Co., Ltd., established on 2010-12-22, Business scope includes raw materials,Pharmaceutical Intermediates,Research and development of new drugs,Production,Sales,Import and export and related technical consultation,Serve;Hazardous Chemicals Management(Operate according to the scope listed in the license);road freight transport(A license or approval is required to operate).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yichang HEC Changjiang Pharmaceutical Co. Ltd. a PRC pharmaceutical manufacturing company that focuses on the development, manufacturing and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases and cardiovascular diseases. We currently manufacture, market and sell a total of 33 pharmaceutical products in the PRC, and we have established an extensive distribution network within the PRC.

Shanghai Techwell Biopharmaceutical Co. Ltd. is a Chinese private company located in Shanghai. The firm specializes in research, development and production of APIs and injections.

Tirsch (Nanjing) Drug Research and Development Co., Ltd., established on 2015-12-15, Business scope includes new drug research and development,Chemical synthesis and manufacturing of drug-related compounds;medicine,cosmetic,Development of detection technology in the field of agricultural products and environmental technology,technical consulting,Technical Services and Technology Transfer;Import and export of drug-related compounds,commission agent(outside the auction).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Ruichuang Kangtai Pharmaceutical Research Institute Co., Ltd., established on 2014-04-22, Business scope includes medical research and experimental development;Drug Technology Development,technology transfer,Technical Services;retail chemical products(Free of Hazardous Chemicals).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Shenzhen Xinyan Biotechnology Co., Ltd., established on 2015-09-22, Business scope includes general business items:Technical development of biological products,technical consulting,technology transfer,Technical Services:Medical Technology Development,consult,transfer;chemical reagent,laboratory instrument,Development, purchase and sale of electronic products;Domestic Trade;Impurities,Reference substance,Chemical Products(Does not contain flammable and explosive chemical hazards)development and sales of;engaged in goods,Technology import and export business;Acting drug declaration and registration.,The licensing program is:Manufacturing of pharmaceutical intermediates;Product development and sales of biomedicine and medical devices.

Wuhan Jia Nuo Kang Pharmaceutical Technology Co., Ltd., established on 2015-06-24, Business scope includes licensed projects:Drug import and export;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;marketing planning;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Xianggen Biomedicine Co., Ltd., established on 2018-12-10, Business scope includes general business items:new drug,R&D of pharmaceutical intermediates,Sales;Research and development of biomedicine and medical devices,detection,technology transfer,technical consulting;Domestic Trade;Import and export,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated);Research and development of chemical compounds,technology transfer,technical consulting(No restricted items);Information Technology Services;Provide investment consulting and management services for enterprises;Consulting management services permitted by law in other countries.,The licensing program is:Research and development, purchase and sale of biomedicine and medical device technology(no law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).

Hunan Mingrui Pharmaceutical Co., Ltd., established on 1992-08-04, The business scope includes chemical pharmaceutical raw materials,Manufacture of chemical preparations;Chinese patent medicine production;Chemical raw materials and their preparations,Chemicals,Wholesale of Chinese patent medicine;Research and development of new specialty drugs.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Fukang Pharmaceutical engages in the R&D, production, and sales of characteristic APIs, and pharmaceutical products. It has distinct competitive advantages in product differentiation and prominent standardized market advantages. Advanced drug research and development advantages, rich product variety advantages, scientific manufacturing advantages, and substantial core team advantages, continue to provide a good health guarantee for a high-quality human life.

Guilin Southern Pharmaceutical Co., Ltd., established on 2001-06-22, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Import and export of goods managed by state trade;road freight transport(Web Freight);road transport of dangerous goods;road freight transport(Does not contain dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Chinese herbal extracts;Manufacturing of medical packaging materials;Sales of packaging materials and products;Technology Import and Export;Import and export agency;Import and export;trade broker;Air International Freight Forwarder;Maritime International Freight Forwarding Agency;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhuhai Anzhe Biotechnology Co., Ltd., established on 2017-09-01, Business scope includes pharmacy,Research on Controlled Chinese Medicinal Materials Used in Traditional Chinese Medicine and Testing,production and sales,Research on Standard and Reference Substances for Drug Testing,Production,Sales,Research on intermediates and plant extraction,Drug Synthesis Technology,Fine Chemicals,Instruments and consumables,Engaged in the import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Hybio Pharmaceutical Co., Ltd. (翰宇药业) is a high-tech enterprise which is engaged in research, development, production, and sales of polypeptide drugs. On the basis of strict production management and quality control according to the GMP strictly, it breaks through the bottle-neck of the polypeptide drugs' large-scale production technology by means of introduction digestion, independent innovation, and any other patterns. Shenzhen Hybio Pharmaceutical has successively applied for 38 patents, with 5 patents for invention, 7 national new drug certificates, 5 new drug clinical trial permissions, and 45 drug registration letters. The drugs are mainly used to treat diseases such as digestive diseases, cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, tumors, senile diseases, and more.